DMBT1 Protein (AA 2008-2413) (His tag)

Produktnummer ABIN7399658

Produktdetails

Target: DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))

Protein-Typ: Recombinant

Proteineigenschaft: AA 2008-2413

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses DMBT1 Protein ist gelabelt mit His tag.

Applikation: Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)

Sequenz: Cys2008-Arg2413

Produktmerkmale: Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1), Prokaryotic expression, Cys2008-Arg2413, N-terminal His Tag

Reinheit: > 95 %

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Isoelectric Point:6.7

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-80 °C

Informationen zur Lagerung: Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Haltbarkeit: 12 months

Antigendetails

Target: DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))

Andere Bezeichnung: Deleted In Malignant Brain Tumors 1 (DMBT1 Produkte)

Synonyme: GP340 Protein, muclin Protein, CRP Protein, CRP-[a] Protein, CRP-[b] Protein, Crpd Protein, DBMT1 Protein, gp300 Protein, p80 Protein, DMBT1 Protein, gp340 Protein, deleted in malignant brain tumors 1 Protein, deleted in malignant brain tumors 1 protein Protein, gp340 Protein, deleted in malignant brain tumors 1 S homeolog Protein, DMBT1 Protein, Dmbt1 Protein, LOC100064515 Protein, dmbt1 Protein, ST201phi2-1p340 Protein, dmbt1.S Protein

Hintergrund: GP340, SAG, Muclin, Glycoprotein 340, Hensin, Salivary agglutinin, Surfactant pulmonary-associated D-binding protein

Molekulargewicht: 50kDa

UniProt: Q9UGM3

Pathways: Activation of Innate immune Response